Swissmedic 就外国生产商 GMP 合规评估召开圆桌会议并公布纪要
Switzerland: GMP Compliance by Foreign Manufacturers
Swissmedic 于 2026 年 8 月 13 日召开 GMP/GDP 特别圆桌会议,与行业协会讨论上市许可申请中外国生产商 GMP 合规评估的简化方案,并例外公开了会议纪要。会上 Swissmedic 介绍了核实外国生产商 GMP 合规证据的新规定与澄清,并列举当前常见的拒绝理由;行业方则说明实施问题、现有模糊之处及当前政治与监管环境下的挑战。会议纪要仅提供德文版本。
In Switzerland, the Swissmedic has been in direct discussions with industry associations regarding possible simplifications in the assessment of GMP compliance by foreign manufacturers and has clarified outstanding issues. An extraordinary GMP/GDP roundtable held on 13 August 2026 focused on the GMP compliance of foreign manufacturers in the context of marketing authorisation applications, as well as on possible joint and concrete solutions and approaches. The aim is to simplify procedures and make them more efficient. Given the importance of the topic, Swissmedic has, as an exception, published the minutes of the roundtable. The Swissmedic provided information on the new provisions and clarifications regarding evidence for verifying the GMP compliance of foreign manufacturers. Examples of current grounds for rejection were cited, and up-to-date approaches were presented. The industry presented the current situation, current challenges and its feedback from practical experience. The focus was particularly on implementation issues, existing ambiguities, the impact on the companies concerned and the increasing challenges in the current political and regulatory environment. Further details can be found in the press release and the meeting minutes (only available in German).
来源:ECA GMP News · gmp-compliance.org